Welcome to BIO CEO & Investor Digital Conference

We are excited to welcome you to day one of the BIO CEO & Investor Digital Conference! Here's a preview of today's schedule – packed with interactive educational sessions, fireside chats, on-demand company presentations and virtual networking opportunities!

Tip: The links below take you directly to sessions in the BIO Education Platform. Please make sure you are logged in so you can click through directly to the event you want to attend.


Schedule of Events: Tuesday, February 16

Please note all session times below are in Eastern Standard Time (EST):

Biotech's Finest Hour: A Discussion on Corporate Leadership and Equity
10:15AM - 11:00AM EST
Join us for an in-depth conversation with BIO’s President and CEO, Dr. Michelle McMurry-Heath and Nasdaq’s President and CEO, Adena T. Friedman on key initiatives in financial services and biotechnology that will shape the future.

Pioneering Innovations in Cancer Drug Development
11:00AM - 12:00PM EST
Join officers from leading companies as they conduct a deep-dive on the most exciting developments, while also acknowledging the obstacles, as the industry considers what the future holds for this important area of research.

Fireside Chat: Rahul Singhvi, SC.D., M.B.A, Chief Executive Officer and Director, National Resilience, Inc.
12:00PM - 1:00PM EST
Rahul Singhvi is a global leader in the Life Sciences industry and serves as the Chief Executive Officer of National Resilience, Inc.

Networking Hour

Join us today from 1:00 - 2:00 pm EST to interact live with a new group of companies!

CEO Remo Floorplan Gif


Investors and attendees can connect via video conferencing for face-to-face discussion with presenting companies. Access these networking opportunities via the "Networking Pavilion" in the BIO Education Platform. Simply click the link to join, complete your profile and enter the room to start networking! Here is a Quick Start Guide to Networking.

SPACs: Criteria for Successful Launches
2:00PM - 3:00PM EST
Biotech SPACs (special purpose acquisition companies) have reached record levels in 2020. As companies consider options for accessing capital and investors seek new opportunities, attend this session to hear about the benefits and risks of this vehicle.

China as an Emerging Center of Innovation
3:00PM - 4:00PM EST
What is driving this revolution in Chinese biotech? How has the wider community responded? Join experts from pharma, biotech and venture as they discuss what factors are contributing to this radical transformation.

Deal Making in a New Decade: Lessons Learned and Planning for Tomorrow
4:00PM - 5:00PM EST
The emergence of COVID-19 disrupted the status quo for businesses across the industry. With record collaboration and innovation, companies have adapted to this new landscape. Hear how companies and investors consider priorities for 2021 and beyond.